429 results on '"Bremer, B."'
Search Results
2. Charlie Is Our Darling
3. Function Preserving Projection (FPP): A Linear Projection Technique for Visual Interpretation of High-Dimensional Functions
4. Evolutionary history of the Afro-Madagascan Ixora species (Rubiaceae): species diversification and distribution of key morphological traits inferred from dated molecular phylogenetic trees
5. Historical biogeography of the coffee family (Rubiaceae, Gentianales) in Madagascar: case studies from the tribes Knoxieae, Naucleeae, Paederieae and Vanguerieae
6. Phylogeny of the complex Vanguerieae (Rubiaceae) genera Fadogia, Rytigynia, and Vangueria with close relatives and a new circumscription of Vangueria
7. Cross-genotype-specific T-cell responses in acute hepatitis E virus (HEV) infection
8. Studies in the tribe Spermacoceae (Rubiaceae-Rubioideae): the circumscriptions of Amphiasma and Pentanopsis and the affinities of Phylohydrax
9. Nuclear rDNA ITS sequence data used to construct the first phylogeny of Vanguerieae (Rubiaceae)
10. A phylogenetic analysis of 100 + genera and 50 + families of euasterids based on morphological and molecular data with notes on possible higher level morphological synapomorphies
11. Selagineae and Manuleeae, two tribes or one? Phylogenetic studies in the Scrophulariaceae
12. Phylogeny and classification of the subfamily Rubioideae (Rubiaceae)
13. Early HCV RNA kinetics predict relapse to sofosbuvir/ribavirin dual therapy: O-27
14. Fruit Characteristics, Life Forms, and Species Richness in the Plant Family Rubiaceae
15. Phylogenetic utility of the nuclear rDNA ITS region in subfamily Ixoroideae (Rubiaceae): comparisons with cpDNA rbcL sequence data
16. Assoziation zwischen niedrigen Anti-HBc Level und niedriegerem Risiko eines virologischen Relapse nach Absetzen von Nukleos(t)id Analoga in HBe Antigen negativen Patienten
17. Strategic Interdependence and Preferences for Debt Mutualization in the Eurozone
18. Development and evaluation of a baseline-event-anticipation score for hepatitis delta
19. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients
20. A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reduction
21. Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study
22. Ontwikkeling van onderwijsarrangementen voor een succesvolle doorstroom vmbo-mbo-hbo: Onderzoeksrapportage
23. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D
24. The Coronavirus Is Reducing Merkel’s EU Legacy to Ashes
25. HBcrAg levels are associated with virological response to treatment with interferon in patients with hepatitis delta
26. Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir
27. A phylogenetic analysis of 100+ genera and 50+ families of euasterids based on morphological and molecular data with notes on possible higher level morphological synapomorphies
28. Familial isolated parathyroid adenoma in a consanguineous family
29. Chronic Hepatitis E in Heart Transplant Recipients
30. Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country?
31. Phylogenetic utility of the nuclear rDNA ITS region in subfamilyIxoroideae (Rubiaceae): Comparisons with cpDNArbcL sequence data
32. Pharmakokinetik von Meropenem in Aszites und Plasma bei PatientInnen mit nosokomialer spontan bakterieller Peritonitis und Leberzirrhose
33. Dental implants in patients with orofacial clefts: a long-term follow-up study
34. Is the euro up for grabs? Evidence from a survey experiment
35. Model compounds for the oxidized uteroferrin-phosphate complex with novel dinucleating ligands containing phenolate and pyridine donors
36. Viral dominance patterns in chronic hepatitis delta determine early response to interferon alpha therapy
37. Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
38. Long-term outcome of hepatitis delta compared to HBV monoinfection
39. Reduction of serum infectivity of hepatitis Delta virus-infected patients treated with Myrcludex B: An in vitro assay to determine infectious units
40. Beziehungen zwischen Fettsäurestoffwechsel und Ketonkörperbildung unter dem Einfluß von Noradrenalininfusionen bei normalen, übergewichtigen und diabetischen Menschen
41. Hepatitis E virus-specific T cell responses against non-structural viral proteins in patients with ongoing and resolved hepatitis E
42. Whole genome deep sequencing is superior to sequencing only regions of special interest for the characterization of HDV evolution
43. Does response to antiviral therapy affect the clinical long-term outcome of hepatitis delta?
44. Erstbeschreibung der T-Zellantwort gegen das gesamte Genom des Hepatitis E Virus
45. SAT-369 - Reduction of serum infectivity of hepatitis Delta virus-infected patients treated with Myrcludex B: An in vitro assay to determine infectious units
46. FRI-288 - Long-term outcome of hepatitis delta compared to HBV monoinfection
47. GS-005 - Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
48. Clinical Utility of Hepatitis B Core-Related Antigen (HBcrAg) in the Treatment of Hepatitis Delta
49. Partially Restored T Cell Responses in HBEAG-Negative Chronic Patients after Stopping NA therapy
50. Does Antiviral Treatment Affect the Clinical Long-Term Outcome of Hepatitis Delta?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.